PLLA vs PCL vs PDLLA comes down to polymer chemistry and particle design. All three are biodegradable polyesters used as collagen stimulators, but they differ in structure, handling and manufacturer-stated duration. Published head-to-head human data is limited, so product selection should rest on technique, training and local regulation.
Key Takeaways
- PLLA, PCL and PDLLA are all aliphatic polyesters with biodegradable, biocompatible and biostimulatory properties.
- PLLA is made only of L-lactic acid; PDLLA contains both D- and L-lactic acid in varying proportions.
- In one randomized split-face trial, PDLLA and PLLA performed comparably for nasolabial folds at 24 weeks.
- Duration figures on product pages are manufacturer claims; results vary between patients.
- Sourcing, authenticity and licensing checks matter as much as the polymer choice.
What are PLLA, PCL and PDLLA collagen stimulators?
They are injectable polymer-based products designed to prompt the body's own collagen production rather than simply add volume with a gel. The literature groups PLLA (poly-L-lactic acid), PCL (polycaprolactone), PDLLA (poly-D,L-lactic acid) and PDO as aliphatic polyesters that are biodegradable, biocompatible and biostimulatory.
In the HolyPath catalogue these are represented by Olidia PLLA (365 mg), GOURI fully liquid PCL and AestheFill PDLLA. Related PDLLA-based volumizing options include Juvelook Volume.
How do PLLA and PDLLA differ structurally?
PLLA consists only of L-lactic acid, while PDLLA combines D- and L-lactic acid in various proportions. A 2025 randomized trial description characterizes PLLA as irregularly shaped, spiky particles with a densely packed interior, and PDLLA as smooth spongiform microspheres with a porous, reticular interior that permits faster degradation and gradual release of breakdown products.
A separate letter in the same literature describes the PDLLA microspheres studied as 30 to 70 µm in size with surface micropores. For PLLA, a review of biostimulators reports particle major-axis lengths of 2 to 150 µm, with a notable share of particles under 20 µm.
How does the biology of collagen stimulation work?
Polymer particles are recognised by the tissue as foreign material, and the resulting cellular response drives collagen formation. For PLLA, published work describes an immune-mediated pathway involving M1 and M2 macrophages, with TGF-β upregulation in fibroblasts. For PDLLA, the proposed pathway involves M2 macrophage NRF2 expression, which stimulates collagen production.
In animal tracking of a PDLLA filler over 24 weeks, inflammatory cells were seen at week 2, decreased by week 4, and collagen increased progressively through week 20, with no migration of the injected volume noted at week 24. These are animal findings and should not be extrapolated directly to clinical outcomes.
How do PLLA, PCL and PDLLA compare side by side?
The table summarizes what can be stated from the sources reviewed. Duration entries are manufacturer-stated and not independently verified.
| Feature | PLLA (Olidia) | PCL (GOURI) | PDLLA (AestheFill) |
|---|---|---|---|
| Polymer | Poly-L-lactic acid | Solubilized polycaprolactone, 21% PCL per product page | Poly-D,L-lactic acid with sodium CMC |
| Presentation | 365 mg per vial | 1 ml pre-filled syringe | 200 mg lyophilized powder per vial (154 mg PDLLA, 46 mg CMC) |
| Preparation | Not stated on product page | Fully liquid per product name | Mix with 5–7 ml sterile water; optional 1 ml lidocaine |
| Storage | 1–30 °C, away from sunlight | 1–30 °C, avoid sunlight and freezing | 1–30 °C, dry place |
| Stated duration | Up to 24 months | 12–24 months | 18–24 months |
| Stated areas | Deep wrinkles, nasolabial folds, temples, facial volume loss | Entire face excluding glabella and nose | Cheeks, temples, jawline, nasolabial and marionette lines |
What does clinical evidence say about PLLA vs PDLLA?
A randomized, evaluator-blinded, split-face multi-center trial of 33 participants compared a PDLLA-based filler (Juvelook Volume) with PLLA (Sculptra) for nasolabial folds. Participants received three injections at 4-week intervals and were assessed through 24 weeks.
Both products produced significant wrinkle improvement from baseline (p < 0.001). Wrinkle Severity Rating Scale reductions were −1.37 for PDLLA and −1.20 for PLLA at week 24, with no statistically significant difference, supporting non-inferiority. This is one trial in one indication; it does not settle comparisons with PCL products.
Why does polymer design matter for injectors?
Particle shape, size and degradation behavior influence how a product disperses in tissue and how the body responds to it. This is why published authors discuss crystallinity, microsphere porosity and phagocytosable particle fractions rather than only the polymer name.
For PLLA, the review cited below notes a substantial proportion of particles under 20 µm, which can be phagocytosed, compared with a much smaller share for CaHA-CMC microspheres. For PDLLA, the porous microsphere structure is described as allowing faster degradation. Neither observation replaces the manufacturer's instructions for use, and the handling rules for each product should be learned through formal training.
Why are results described as gradual?
Collagen stimulators act through a tissue response that unfolds over weeks to months rather than at the moment of injection. In the PLLA vs PDLLA trial, three sessions were given four weeks apart and outcomes were measured out to week 24. A separate human trial summary describes maximum improvement for a PDLLA filler at around six months. Practitioners should set patient expectations accordingly and avoid promising specific outcomes, since results vary.
How should a distributor evaluate a collagen stimulator supplier?
A sound supplier can document origin, batch details and storage conditions, and will only sell to verified licensed buyers. Because these are prescription medical products, import rules and registration requirements differ between countries, so local confirmation comes first.
- Confirm the manufacturer and the exact product name, strength and presentation on the packaging.
- Ask for the supplier's trade documentation and how products are stored and shipped.
- Check that the product is permitted for import and professional use in your market.
- Keep batch records so that any adverse event can be traced and reported.
HolyPath supplies certified Korean aesthetic products to clinics, practitioners and distributors, and its team can share product specifications on request.
For clinics building a regenerative menu, collagen stimulators sit alongside skin boosters and neurotoxins rather than replacing them; each addresses a different tissue target, and combination planning belongs with the treating practitioner.
What should clinics and distributors check before choosing?
Verify the regulatory status in your own jurisdiction, authenticity, storage conditions and practitioner training before stocking any product. Approval status differs by country and should be confirmed with the local regulator rather than assumed from a product page.
- Training: Technique, depth and dilution differ between products, so follow the manufacturer's instructions for use.
- Documentation: Request batch information and supplier credentials.
- Handling: Room-temperature storage ranges listed above still require protection from light and, for GOURI, from freezing.
- Combination plans: See our combination protocol guide and the Elravie Re2O ECM explainer for related regenerative options.
Frequently Asked Questions
Is PLLA better than PCL or PDLLA?
No single polymer is better in every case. In a randomized split-face trial of 33 participants, a PDLLA-based filler and a PLLA product showed comparable nasolabial fold improvement at 24 weeks. Choice depends on the treatment area, practitioner experience, product handling and local regulatory status.
What is the difference between PLLA and PDLLA?
PLLA is built only from L-lactic acid, while PDLLA contains varying proportions of D- and L-lactic acid. Published descriptions characterize PLLA particles as irregular and densely packed, and PDLLA microspheres as porous and spongiform, which is associated with faster degradation.
Are PCL fillers the same as hyaluronic acid fillers?
No. HA fillers provide volume from a hydrophilic gel, whereas PCL products such as GOURI are positioned as collagen stimulators. PCL is an aliphatic polyester with biodegradable, biocompatible and biostimulatory properties, so the treatment goal and injection technique differ from an HA filler.
How long do collagen stimulator results last?
Duration varies by product, area and patient. Manufacturers state up to 24 months for Olidia, 12 to 24 months for GOURI and 18 to 24 months for AestheFill. These are manufacturer claims, not guarantees, and independent data should be reviewed by each clinic.
Can distributors supply collagen stimulators to any buyer?
No. These are prescription medical products intended for licensed professionals. Distributors should verify the buyer's licence, confirm local import and registration rules, and check authenticity and cold-chain or storage documentation before supply.
Conclusion
PLLA, PCL and PDLLA each offer a distinct particle design and handling profile, and the best choice depends on the practitioner, the area treated and local regulation. Clinics and distributors who want product specifications for Olidia, GOURI or AestheFill can contact HolyPath through the inquiry page.
References
- Randomized split-face trial: PDLLA (Juvelook Volume) vs PLLA (Sculptra) for nasolabial folds, PubMed Central
- Letter on PLLA, PCL, PDO and PDLLA filler properties, PubMed Central
- CaHA-CMC and PLLA biostimulator mechanisms and particle sizes, PubMed Central
- GOURI product page, HolyPath
This article is for informational purposes for licensed medical professionals and distributors. It is not medical advice. Treatments should be performed only by qualified practitioners in accordance with local regulations.